155 related articles for article (PubMed ID: 22171602)
1. Development and validation of novel AAV2 random libraries displaying peptides of diverse lengths and at diverse capsid positions.
Naumer M; Ying Y; Michelfelder S; Reuter A; Trepel M; Müller OJ; Kleinschmidt JA
Hum Gene Ther; 2012 May; 23(5):492-507. PubMed ID: 22171602
[TBL] [Abstract][Full Text] [Related]
2. Impact of capsid modifications by selected peptide ligands on recombinant adeno-associated virus serotype 2-mediated gene transduction.
Naumer M; Popa-Wagner R; Kleinschmidt JA
J Gen Virol; 2012 Oct; 93(Pt 10):2131-2141. PubMed ID: 22764318
[TBL] [Abstract][Full Text] [Related]
3. Insertional mutagenesis of the adeno-associated virus type 2 (AAV2) capsid gene and generation of AAV2 vectors targeted to alternative cell-surface receptors.
Shi W; Arnold GS; Bartlett JS
Hum Gene Ther; 2001 Sep; 12(14):1697-711. PubMed ID: 11560765
[TBL] [Abstract][Full Text] [Related]
4. Novel random peptide libraries displayed on AAV serotype 9 for selection of endothelial cell-directed gene transfer vectors.
Varadi K; Michelfelder S; Korff T; Hecker M; Trepel M; Katus HA; Kleinschmidt JA; Müller OJ
Gene Ther; 2012 Aug; 19(8):800-9. PubMed ID: 21956692
[TBL] [Abstract][Full Text] [Related]
5. Insertional mutagenesis at positions 520 and 584 of adeno-associated virus type 2 (AAV2) capsid gene and generation of AAV2 vectors with eliminated heparin- binding ability and introduced novel tropism.
Shi X; Fang G; Shi W; Bartlett JS
Hum Gene Ther; 2006 Mar; 17(3):353-61. PubMed ID: 16544984
[TBL] [Abstract][Full Text] [Related]
6. Peptide ligands incorporated into the threefold spike capsid domain to re-direct gene transduction of AAV8 and AAV9 in vivo.
Michelfelder S; Varadi K; Raupp C; Hunger A; Körbelin J; Pahrmann C; Schrepfer S; Müller OJ; Kleinschmidt JA; Trepel M
PLoS One; 2011; 6(8):e23101. PubMed ID: 21850255
[TBL] [Abstract][Full Text] [Related]
7. Engineering adeno-associated virus serotype 2-based targeting vectors using a new insertion site-position 453-and single point mutations.
Boucas J; Lux K; Huber A; Schievenbusch S; von Freyend MJ; Perabo L; Quadt-Humme S; Odenthal M; Hallek M; Büning H
J Gene Med; 2009 Dec; 11(12):1103-13. PubMed ID: 19777441
[TBL] [Abstract][Full Text] [Related]
8. RGD inclusion in VP3 provides adeno-associated virus type 2 (AAV2)-based vectors with a heparan sulfate-independent cell entry mechanism.
Shi W; Bartlett JS
Mol Ther; 2003 Apr; 7(4):515-25. PubMed ID: 12727115
[TBL] [Abstract][Full Text] [Related]
9. Adeno-associated virus type 2 VP2 capsid protein is nonessential and can tolerate large peptide insertions at its N terminus.
Warrington KH; Gorbatyuk OS; Harrison JK; Opie SR; Zolotukhin S; Muzyczka N
J Virol; 2004 Jun; 78(12):6595-609. PubMed ID: 15163751
[TBL] [Abstract][Full Text] [Related]
10. Two novel adeno-associated viruses from cynomolgus monkey: pseudotyping characterization of capsid protein.
Mori S; Wang L; Takeuchi T; Kanda T
Virology; 2004 Dec; 330(2):375-83. PubMed ID: 15567432
[TBL] [Abstract][Full Text] [Related]
11. Isolation of targeted AAV2 vectors from novel virus display libraries.
Waterkamp DA; Müller OJ; Ying Y; Trepel M; Kleinschmidt JA
J Gene Med; 2006 Nov; 8(11):1307-19. PubMed ID: 16955542
[TBL] [Abstract][Full Text] [Related]
12. Vector Affinity and Receptor Distribution Define Tissue-Specific Targeting in an Engineered AAV Capsid.
Martino RA; Wang Q; Xu H; Hu G; Bell P; Arroyo EJ; Sims JJ; Wilson JM
J Virol; 2023 Jun; 97(6):e0017423. PubMed ID: 37199615
[TBL] [Abstract][Full Text] [Related]
13. Genetic capsid modifications allow efficient re-targeting of adeno-associated virus type 2.
Girod A; Ried M; Wobus C; Lahm H; Leike K; Kleinschmidt J; Deléage G; Hallek M
Nat Med; 1999 Sep; 5(9):1052-6. PubMed ID: 10470084
[TBL] [Abstract][Full Text] [Related]
14. Random peptide libraries displayed on adeno-associated virus to select for targeted gene therapy vectors.
Müller OJ; Kaul F; Weitzman MD; Pasqualini R; Arap W; Kleinschmidt JA; Trepel M
Nat Biotechnol; 2003 Sep; 21(9):1040-6. PubMed ID: 12897791
[TBL] [Abstract][Full Text] [Related]
15. Optimization of design and production strategies for novel adeno-associated viral display peptide libraries.
Körbelin J; Hunger A; Alawi M; Sieber T; Binder M; Trepel M
Gene Ther; 2017 Aug; 24(8):470-481. PubMed ID: 28622288
[TBL] [Abstract][Full Text] [Related]
16. Altering AAV tropism with mosaic viral capsids.
Gigout L; Rebollo P; Clement N; Warrington KH; Muzyczka N; Linden RM; Weber T
Mol Ther; 2005 Jun; 11(6):856-65. PubMed ID: 15922956
[TBL] [Abstract][Full Text] [Related]
17. Transposon-based mutagenesis generates diverse adeno-associated viral libraries with novel gene delivery properties.
Koerber JT; Schaffer DV
Methods Mol Biol; 2008; 434():161-70. PubMed ID: 18470644
[TBL] [Abstract][Full Text] [Related]
18. Selection of muscle-binding peptides from context-specific peptide-presenting phage libraries for adenoviral vector targeting.
Ghosh D; Barry MA
J Virol; 2005 Nov; 79(21):13667-72. PubMed ID: 16227286
[TBL] [Abstract][Full Text] [Related]
19. Vectors selected from adeno-associated viral display peptide libraries for leukemia cell-targeted cytotoxic gene therapy.
Michelfelder S; Lee MK; deLima-Hahn E; Wilmes T; Kaul F; Müller O; Kleinschmidt JA; Trepel M
Exp Hematol; 2007 Dec; 35(12):1766-76. PubMed ID: 17920758
[TBL] [Abstract][Full Text] [Related]
20. Insight into the mechanisms of enhanced retinal transduction by the engineered AAV2 capsid variant -7m8.
Khabou H; Desrosiers M; Winckler C; Fouquet S; Auregan G; Bemelmans AP; Sahel JA; Dalkara D
Biotechnol Bioeng; 2016 Dec; 113(12):2712-2724. PubMed ID: 27259396
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
